Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 24.56% | 11.51% | -5.93% | -16.40% | -39.02% |
| Total Depreciation and Amortization | 7.22% | 23.86% | 34.18% | 34.21% | 53.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.42% | 4.48% | 20.91% | 25.90% | 19.73% |
| Change in Net Operating Assets | -141.35% | -299.66% | -374.43% | -145.88% | -3.97% |
| Cash from Operations | 23.37% | 6.42% | -13.29% | -23.47% | -43.61% |
| Capital Expenditure | 69.29% | 88.24% | 15.00% | -21.74% | -284.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -256.72% | -171.82% | -128.98% | -214.78% | 163.43% |
| Cash from Investing | -264.94% | -175.79% | -132.10% | -219.88% | 160.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.71% | 80.77% | -12.22% | -79.74% | 30.52% |